Skip to main content

Table 2 Comparing clinical, laboratory, and echocardiographic variables at the end of the program

From: Effect of a phase 2 cardiac rehabilitation program on obese and non-obese patients with stable coronary artery disease

Variable Non-obese patients (n = 58) Obese patients (n = 62) p value
Clinical characteristics at the end of the program
 BMI, kg/m2 26.77 ± 1.77 31.97 ± 3.47 < 0.001
 Systolic BP, mmHg 117.41 ± 7.27 120.81 ± 11.19 0.172
 Diastolic BP, mmHg 76.55 ± 5.99 76.77 ± 7.91 0.903
 METs achieved 11.89 ± 2.43 9.82 ± 2.59 0.002
Laboratory tests at the end of the program
 Total cholesterol, mg/dl 138.41 ± 29.53 151.13 ± 25.95 0.081
 LDL-C, mg/dl 78.37 ± 27.34 95.86 ± 26.45 0.015
 HDL-C, mg/dl 44.00 ± 8.46 43.74 ± 7.95 0.903
 Triglycerides, mg/dl 122.49 ± 63.73 129.48 ± 48.44 0.633
 Fasting blood sugar, mg/dl 95.62 ± 22.24 101.87 ± 23.01 0.290
Echocardiographic parameters at the end of the program
 LVEDD, mm 52.17 ± 4.51 52.35 ± 4.66 0.878
 LVESD, mm 36.10 ± 5.09 35.84 ± 4.75 0.836
 LVEF, % 56.83 ± 7.83 57.35 ± 8.95 0.809
  1. Continuous variables are expressed as mean and standard deviation whereas categorical variables are expressed as number (percentage)
  2. BMI body mass index, BP blood pressure, METs metabolic equivalent of tasks, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, LVEDD left ventricular end-diastolic diameter, LVESD left ventricular end-systolic diameter, LVEF left ventricular ejection fraction